You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer

Article metrics

Article menu

Download PDFPDF

Research Article
A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2025

AbstractFullPdf
Dec 2019550
Jan 202012120
Feb 202017172
Mar 202019196
Apr 202013133
May 2020292921
Jun 202029291
Jul 202025256
Aug 2020664
Sep 2020313113
Oct 202031319
Nov 202019193
Dec 202015153
Jan 2021151510
Feb 202117179
Mar 202124248
Apr 2021252510
May 202122224
Jun 202122222
Jul 202126265
Aug 202112124
Sep 202127276
Oct 202130309
Nov 202122223
Dec 202125253
Jan 202234353
Feb 2022191913
Mar 202223236
Apr 202227285
May 202232323
Jun 202227273
Jul 202222236
Aug 202242424
Sep 202241415
Oct 2022414211
Nov 2022121413
Dec 202225265
Jan 202314142
Feb 202345450
Mar 202334354
Apr 202319205
May 202318186
Jun 202313130
Jul 202312127
Aug 202318182
Sep 202341417
Oct 202317177
Nov 202319192
Dec 202320206
Jan 2024646516
Feb 202417175
Mar 2024262616
Apr 202423245
May 202422229
Jun 2024262714
Jul 2024363714
Aug 202420205
Sep 202419236
Oct 2024212110
Nov 2024303114
Dec 2024111113
Jan 2025303016
Feb 2025161612
Mar 2025383925
Apr 2025444413
May 202516178
Jun 202523238
Total16151635478